Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

by A. Quintanal-Villalonga, Luis Paz-Ares, Irene Ferrer, S. Molina-Pinelo
Published 2018-01-01

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications

by A. Quintanal-Villalonga, Luis Paz-Ares, Irene Ferrer, S. Molina-Pinelo
Published 2016-01-01

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

by Ángela Marrugal, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo, Irene Ferrer
Published 2016-01-01

Autotoxicity of Diterpenes Present in Leaves of <i>Cistus ladanifer</i> L.

by Natividad Chaves Lobón, Irene Ferrer de la Cruz, Juan Carlos Alías Gallego
Published 2019-01-01

Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”

by Ángela Marrugal, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo, Irene Ferrer
Published 2018-01-01

Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.

by Carmen Blanco-Aparicio, Marta Cañamero, Yolanda Cecilia, Belén Pequeño, Oliver Renner, Irene Ferrer, Amancio Carnero
Published 2010-01-01

Characterization of the p53 response to oncogene-induced senescence.

by Lidia Ruiz, Magali Traskine, Irene Ferrer, Estrella Castro, Juan F M Leal, Marcelline Kaufman, Amancio Carnero
Published 2008-01-01

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry

by Ángela Marrugal, Irene Ferrer, Maria Dolores Pastor, Laura Ojeda, Álvaro Quintanal-Villalonga, Amancio Carnero, Sonia Molina-Pinelo, Luis Paz-Ares
Published 2019-07-01

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma

by Ángela Marrugal, Irene Ferrer, David Gómez-Sánchez, Álvaro Quintanal-Villalonga, María Dolores Pastor, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo
Published 2021-03-01

Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy

by Sergio González Rubio, Sergio González Rubio, Nuria Montero Pastor, Nuria Montero Pastor, Carolina García, Víctor G. Almendro-Vedia, Víctor G. Almendro-Vedia, Irene Ferrer, Irene Ferrer, Paolo Natale, Paolo Natale, Luis Paz-Ares, Luis Paz-Ares, Luis Paz-Ares, Luis Paz-Ares, M. Pilar Lillo, Iván López-Montero, Iván López-Montero
Published 2018-11-01

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

by Irene Ferrer, Álvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Jose Manuel Garcia-Heredia, Marco Perez, Rocío Suárez, Santiago Ponce-Aix, Luis Paz-Ares, Amancio Carnero
Published 2018-08-01

Immune Deficiency in Jacobsen Syndrome: Molecular and Phenotypic Characterization

by Raquel Rodríguez-López, Fátima Gimeno-Ferrer, Elena Montesinos, Irene Ferrer-Bolufer, Carola Guzmán Luján, David Albuquerque, Carolina Monzó Cataluña, Virginia Ballesteros, Monserrat Aleu Pérez-Gramunt
Published 2021-07-01

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

by Álvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, Cristina Cirauqui, Ángela Marrugal, Laura Ojeda, Santiago García, Jon Zugazagoitia, Sandra Muñoz-Galván, Fernando Lopez-Rios, Luis Montuenga, Silvestre Vicent, Sonia Molina-Pinelo, Amancio Carnero, Luis Paz-Ares
Published 2020-03-01

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

by Donatella Romaniello, Ilaria Marrocco, Nishanth Belugali Nataraj, Irene Ferrer, Diana Drago-Garcia, Itay Vaknin, Roni Oren, Moshit Lindzen, Soma Ghosh, Matthew Kreitman, Jeanette Clarissa Kittel, Nadege Gaborit, Gretchen Bergado Baez, Belinda Sanchez, Raya Eilam, Eli Pikarsky, Luis Paz-Ares, Yosef Yarden
Published 2020-08-01

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

by Sonia Molina-Pinelo, Gabriel Gutiérrez, Maria Dolores Pastor, Marta Hergueta, Gema Moreno-Bueno, Rocío García-Carbonero, Ana Nogal, Rocío Suárez, Ana Salinas, Francisco Pozo-Rodríguez, Fernando Lopez-Rios, Maria Teresa Agulló-Ortuño, Irene Ferrer, Asunción Perpiñá, José Palacios, Amancio Carnero, Luis Paz-Ares
Published 2014-01-01

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

by Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Hector Pérez-Montoyo, Ana Igea, Purificación Muñoz, Manel Esteller, Angel R. Nebreda, Ander Urruticoechea, Idoia Morilla, Sonia Pernas, Fina Climent, María Teresa Soler-Monso, Ana Petit, Violeta Serra, Aleix Prat, Eva González-Suárez
Published 2017-05-01

Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels

by Fernando López-Ríos, Luis Paz-Ares, Pilar Garrido, Eva M Garrido-Martin, Jose Palacios, Elena Sanchez, Ana Belén Enguita, Javier Ramos-Paradas, Susana Hernández-Prieto, David Lora, Aranzazu Rosado, Tamara Caniego-Casas, Nuria Carrizo, María Teresa Muñoz-Jimenez, Borja Rodriguez, Urbicio Perez-Gonzalez, David Gómez-Sánchez, Irene Ferrer, Santiago Ponce Aix, Ángel Nuñez Buiza
Published 2021-05-01